Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in AVIDITY BIOSCIENCES INC
BNP PARIBAS FINANCIAL MARKETS holds 610,547 shares of RNA (AVIDITY BIOSCIENCES INC), worth $44M as of 2025-Q4. The position was increased (++2137.2% shares). RNA represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$44M
Current Shares
610,547
Total Value Change
+$43.4M
Total Shares Change
+588,939
Other major holders of RNA: VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, JANUS HENDERSON GROUP PLC
Increased |
| 610,547 |
+2137.2% |
| $44M |
| 0.0% |
| $72.15 |
47 |
| 2025-Q3 | Increased | 27,291 | +61.5% | $1.2M | 0.0% | $42.63 | 36 |
| 2025-Q2 | Increased | 16,895 | +29.7% | $479,818 | 0.0% | $29.03 | 30 |
| 2025-Q1 | Decreased | 13,025 | -39.7% | $384,498 | 0.0% | $31.60 | 0 |
| 2024-Q4 | New | 21,608 | - | $628,361 | 0.0% | $29.18 | 34 |